Oracle has committed $205m to an initial public offering for the DNA sequencing technology developer with a $410m target for its close.

SoftBank has divested 57 million of its 625 million shares in the NYSE-listed e-commerce marketplace, having invested $3bn between 2015 and 2018.

The Mastercard-backed payment software provider has raised over $1.2bn pre-IPO and has opted to float on the Nasdaq Global Select Market.

The cancer treatment developer is set to go public in an offering which would represent exits for Pfizer Ventures, Leaps by Bayer and Ipsen.

Arctos Medical, which is developing gene therapies to treat sight loss, had raised $8.1m from investors including Novartis two years ago.

Ideo contributed to female-focused debit card provider Sequin's $5m seed round while Nikon has exited motion data software developer Wrnch.

Foxconn and GoTo Group are contributing to a $250m PIPE deal for the Engie, Panasonic and Sumitomo-backed electric scooter system provider’s reverse takeover.

GV owns a 6.6% stake in the DevOps platform developer, which was valued at $6bn as of a secondary share sale late last year.

The Intel Capital-backed employee management software provider was taken over by HighBar for an undisclosed amount.

JSR is buying semiconductor manufacturing technology producer Inpria, giving an exit to fellow corporates SK Hynix, TSMC, Intel, Air Liquide, Applied Materials and Samsung.